2 options
Guidance for industry : supplemental guidance on testing for replication competent retrovirus in reroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors.
- Format:
- Book
- Government document
- Language:
- English
- Subjects (All):
- Gene therapy--United States--Testing.
- Gene therapy.
- Retroviruses--United States.
- Retroviruses.
- Clinical trials--United States.
- Clinical trials.
- United States.
- Physical Description:
- 1 online resource (i, 13 pages)
- Other Title:
- Supplemental guidance on testing for replication competent retrovirus in reroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors
- Place of Publication:
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]
- Notes:
- Title from PDF title page (viewed on May, 12, 2009).
- "November 2006."
- Includes bibliographical references (pages 10-11).
- OCLC:
- 320838766
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.